Skip to main content

Long-Term Outcome of Children of Rheumatic Disease Patients

  • Chapter
  • First Online:
Contraception and Pregnancy in Patients with Rheumatic Disease

Abstract

Systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome are systemic autoimmune diseases that primarily affect woman of childbearing age. Affected patients can have children; however, their pregnancies are often complicated by maternal and fetal problems. Among these, the most frequent is prematurity, often related to the presence of antiphospholipid antibodies (aPL). Maternal aPL (IgG isotype) can cross the placenta but they do not generally cause any thrombotic event in the neonates; on the other hand, there are other maternal antibodies involved in fetal problems, for example anti-Ro/SSA and anti-La/SSB can cause congenital heart block. Behavior and neuropsychological outcomes of children born to patients with SLE and APS have been a matter of interest although limited data are now available. Common experience of experts in the field is that these children do not show an increased risk of autoimmune disease as in their mothers, and that maternal disease does not seems to impair their intelligence levels.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Andreoli L, Bazzani C, Taraborelli M, Reggia R, et al. Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. Autoimmun Rev. 2010;10: 51–4.

    Article  PubMed  Google Scholar 

  2. Persellin RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis. 1976;27:922.

    PubMed  Google Scholar 

  3. Ostensen M. The influence of pregnancy on blood parameters in patients with rheumatic disease. Scand J Rheumatol. 1984;13:203.

    Article  PubMed  CAS  Google Scholar 

  4. Doria A, Cutolo M, Ghirardello A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 2002;47:202–9.

    Article  PubMed  CAS  Google Scholar 

  5. Doria A, Ghirardello A, Iaccarino L, et al. Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum. 2004;51:989–95.

    Article  PubMed  CAS  Google Scholar 

  6. Doria A, Iaccarino L, Ghirardello A, et al. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Behçet disease. Lupus. 2004;13:690–5.

    Article  PubMed  CAS  Google Scholar 

  7. Doria A, Tincani A, Lockshin MD. Challenges of lupus pregnancies. Rheumatology. 2008;47:iii9–12.

    PubMed  Google Scholar 

  8. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.

    Article  PubMed  Google Scholar 

  9. Yan Yuen S, Krizova A, Ouimet JM, Pope JE. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review. Open Rheumatol J. 2008;2:89–98.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Stagnaro-Green A, Akhter E, Yim C, Davies TF, Magder L, Petri M. Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery. Lupus. 2011;20:690–9.

    Article  PubMed  CAS  Google Scholar 

  11. Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003;30(10):2127–32.

    PubMed  Google Scholar 

  12. Delobel-Ayoub M, Arnaud C, White-Koning M, Casper C, Pierrat V, Garel M, Burguet A, Roze JC, Matis J, Picaud JC, Kaminski M, Larroque B, EPIPAGE Study Group. Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE Study. Pediatrics. 2009;123(6):1485–92.

    Article  PubMed  Google Scholar 

  13. Clowse ME, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol. 2006;107(2 Pt 1):293–9.

    Article  PubMed  Google Scholar 

  14. Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia: Elsevier; 2008.

    Google Scholar 

  15. Marlow N, Wolke D, Bracewell MA, Samara M. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005;352:9–19.

    Article  PubMed  CAS  Google Scholar 

  16. Wolke D, Samara M, Bracewell M, Marlow N. Specific language difficulties and school achievement in children born at 25 weeks of gestation or less. J Pediatr. 2008;152:256–62.

    Article  PubMed  Google Scholar 

  17. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA. 2002;288:728–37.

    Article  PubMed  Google Scholar 

  18. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8(1):110–24.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Larroque B, Ancel PY, Marret S, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet. 2008;371:813–20.

    Article  PubMed  Google Scholar 

  20. Fazzi E, Signorini SG, La Piana R, Bertone C, Misefari W, Galli J, Balottin U, Bianchi PE. Neuro-ophthalmological disorders in cerebral palsy: ophthalmological, oculomotor, and visual aspects. Dev Med Child Neurol. 2012;54(8):730–6.

    Article  PubMed  Google Scholar 

  21. Good WV, Jan JE, Burden SK, Skoczenski A, Candy R. Recent advances in cortical visual impairment. Dev Med Child Neurol. 2001;43:56–60.

    Article  PubMed  CAS  Google Scholar 

  22. Fazzi E, Signorini SG, Bova SM, et al. Spectrum of visual disorders in children with cerebral visual impairment. J Child Neurol. 2007;22(3):249–301.

    Article  Google Scholar 

  23. Fazzi E, Bova SM, Giovenzana A, Signorini S, Uggetti C, Bianchi P. Cognitive visual dysfunctions in preterm children with periventricular leukomalacia. Dev Med Child Neurol. 2009;51(12):974–81.

    Article  PubMed  Google Scholar 

  24. Fazzi E, Galli J, Micheletti S. Visual impairment: a common Sequel of preterm birth. Neoreviews. 2012;13(9):e542–50.

    Article  Google Scholar 

  25. Tincani A, Biasini-Rebaioli C, Andreoli L, Lojacono A, Motta M. Neonatal effects of maternal antiphospholipid syndrome. Curr Rheumatol Rep. 2009;11:70–6.

    Article  PubMed  CAS  Google Scholar 

  26. Motta M, Chirico G, Rebaioli CB, Faden D, Lojacono A, Allegri F, Migliori C, Tincani A. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Perinatol. 2006;23(4):247–51.

    Article  PubMed  Google Scholar 

  27. Boffa MC, Aurousseau MH, Lachassinne E, Dauphin H, Fain O, Le Toumelin P, Uzan M, Piette JC, Derenne S, Boinot C, Avcin T, Motta M, Faden D, Tincani A. European register of babies born to mothers with antiphospholipid syndrome. Lupus. 2004;13(9):713–7.

    Article  PubMed  CAS  Google Scholar 

  28. Mekinian A, Lachassinne E, Nicaise-Roland P, et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis. 2013;72(2):217–22.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Andreoli L, Nalli C, Motta M, Norman GL, Shums Z, Encabo S, Binder WL, Nuzzo M, Frassi M, Lojacono A, Avcin T, Meroni PL, Tincani A. Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their ‘innocent’ profile? Ann Rheum Dis. 2011;70(2):380–3.

    Article  PubMed  CAS  Google Scholar 

  30. De Man YA, Hazes JM, van der Heide H, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum. 2009;60:3196.

    Article  PubMed  Google Scholar 

  31. Bowden AP, Barrett JH, Fallow W, Silman AJ. Women with inflammatory polyarthritis have babies of lower birth weight. J Rheumatol. 2001;28:355.

    PubMed  CAS  Google Scholar 

  32. Langen ES, Chakravarty EF, Liaquat M, El-Sayed YY, Druzin ML. High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol. 2014;31(1):9–14.

    PubMed  Google Scholar 

  33. Marker-Hermann E, Bauer H, Gromnica-Ihle E. Rheumatic diseases in pregnancy. Dtsch Med Wochenschr. 2008;133:2410–4.

    Article  PubMed  CAS  Google Scholar 

  34. Zhou Q, Bian XM, Liu JT. Management of pregnancy with ankylosing spondylitis. Chin Med Sci J. 2012;27:46–9.

    Article  PubMed  CAS  Google Scholar 

  35. Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R, Punzi L, Doria A. Pregnancy and vasculitis: a systematic review of the literature. Autoimmun Rev. 2012;11(6–7): A447–59.

    Article  PubMed  Google Scholar 

  36. Bansal PJ, Tobin MC. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase antibody resulting in neonatal pulmonary haemorrhage and renal involvement. Ann Allergy Asthma Immunol. 2004;93:398–401.

    Article  PubMed  Google Scholar 

  37. Silva F, Specks U, Sethi S, et al. Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis. Am J Kidney Dis. 2009;54:542–5.

    Article  PubMed  Google Scholar 

  38. Cetinkaya R, Odabas AR, Gursan N, et al. Microscopic polyangiitis in a pregnant woman. South Med J. 2002;95(12):1441–3.

    Article  PubMed  Google Scholar 

  39. Hwang I, Chang-Keun L, Yoo B, et al. Necrotizing villitis and decidual vasculitis in the placentas of mothers with Behçet disease. Hum Pathol. 2009;40(1):135–8.

    Article  PubMed  Google Scholar 

  40. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf). 2003;59(3):282–8.

    Article  Google Scholar 

  41. Parke A. Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases. Lupus. 2006;15(11):808–13.

    Article  PubMed  CAS  Google Scholar 

  42. Spinillo A, Viazzo F, Colleoni R, Chiara A, Maria Cerbo R, Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol. 2004;191(1):217–24.

    Article  PubMed  CAS  Google Scholar 

  43. Lee BH, Stoll BJ, McDonald SA, Higgins RD. National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone. Pediatrics. 2008;121(2):289–96.

    Article  PubMed  Google Scholar 

  44. Brucato A, Astori MG, Cimaz R, Villa P, Li Destri M, Chimini L, Vaccari R, Muscarà M, Motta M, Tincani A, Neri F, Martinelli S. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero. Ann Rheum Dis. 2006;65(11):1422–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  45. Costedoat-Chalumeau N, Amoura Z, Duhaut P, Huong DLT, Sebbough D, Wechsler B, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. A study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003;48:3207–11.

    Article  PubMed  CAS  Google Scholar 

  46. Motta M, Tincani A, Faden D, Zinzini E, Chirico G. Antimalarial agents in pregnancy. Lancet. 2002;359:524–5.

    Article  PubMed  Google Scholar 

  47. Klinger G, Morad Y, Westall CA, Laskin C, Spitzer KA, Koren G, et al. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet. 2001;358:813–4.

    Article  PubMed  CAS  Google Scholar 

  48. Cimaz R, Brucato A, Meregalli E, Muscara M, Sergi P. Electroretinograms of children born from mothers treated with hydroxychloroquine (hcq) during pregnancy and breast-feeding. Arthritis Rheum. 2004;50:3056–7.

    Article  PubMed  Google Scholar 

  49. Food US, Administration D. United States FDA pharmaceutical pregnancy categories. Fed Regist. 1980;44:37434–67.

    Google Scholar 

  50. European Medicines Agency. http://www.ema.europa.eu/ema (2010). Accessed 20 Oct 2010.

  51. US Food and Drug Administration. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm. Accessed 20 October

  52. Bogas M, Leandro MJ. Biologic therapy and pregnancy. A systematic literature review. Acta Reumatol Port. 2011;36:219–32.

    PubMed  CAS  Google Scholar 

  53. Airo’ P, Scarsi M, Brucato A, Benicchi T, Malacarne F, Cavazzana I, et al. Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block. Lupus. 2006;15(9):553–61.

    Article  PubMed  Google Scholar 

  54. Airò P, Antonioli CM, Motta M, Faden D, Chirico G, Cattaneo R, Tincani A. The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis. Lupus. 2002;11(7):454–7.

    Article  PubMed  Google Scholar 

  55. Motta M, Tincani A, Meroni PL, Cimaz R. Follow-up of children exposed antenatally to immunosuppressive drugs. Rheumatology. 2008;47:iii32–4.

    Article  PubMed  Google Scholar 

  56. Katzav A, Shoenfeld Y, Chapman J. The pathogenesis of neural injury in animal models of the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2010;38:196–200.

    Article  PubMed  CAS  Google Scholar 

  57. Rodrigues CE, Carvalho JF, Shoenfeld Y. Neurological manifestations of antiphospholipid syndrome. Eur J Clin Invest. 2010;40(4):350–9.

    Article  PubMed  Google Scholar 

  58. Neri F, Chimini L, Bonomi F, Filippini E, Motta M, Faden D, et al. Neuropsychological development of children born to patients with systemic lupus erythematosus syndrome. Lupus. 2004;13:805–11.

    Article  PubMed  CAS  Google Scholar 

  59. Nacinovich R, Galli J, Bomba M, Filippini E, Parrinello G, Nuzzo M, Lojacono A, Motta M, Tincani A. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum. 2008;59(3):345–51.

    Article  PubMed  CAS  Google Scholar 

  60. Ross G, Sammaritano L, Nass R, Lockshin M. Effects of mothers’ autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med. 2003;157(4):397–402.

    Article  PubMed  Google Scholar 

  61. Lahita RG. Systemic Lupus Erythematosus: learning disabilities in the male offspring of female patients and relationship to laterality. Psychoneuroendocrinology. 1988;13:385–96.

    Article  PubMed  CAS  Google Scholar 

  62. McAllister D, Kaplan BJ, Edworthy SM, Martin L, Crawford SG, Ramsey Goldman R, et al. The influence of systemic lupus erythematosus on fetal development: cognitive, behavioral, and health trends. J Int Neuropsychol Soc. 1997;3:370–6.

    PubMed  CAS  Google Scholar 

  63. Urowitz MB, Gladman DD, MacKinnon A, Ibañez D, Bruto V, Rovet J, Silverman E. Neurocognitive abnormalities in offspring of mothers with systemic Lupus Erythematosus. Lupus. 2008;17(6):555–60.

    Article  PubMed  CAS  Google Scholar 

  64. Marder W, Ganser MA, Romero V, Hyzy MA, Gordon C, McCune WJ, Somers EC. In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. Arthritis Care Res. 2013;65:759–66.

    Article  CAS  Google Scholar 

  65. Barkmann C, Romer G, Watson M, Schulte-Markwort M. Parental physical illness as a risk for psychosocial maladjustment in children and adolescents: epidemiological findings from a national survey in Germany. Psychosomatics. 2007;48:476–81.

    Article  PubMed  Google Scholar 

  66. Field T, Diego M, Hernandez-Reif M, et al. Chronic prenatal depression and neonatal outcome. Int J Neurosci. 2008;118:95–103.

    Article  PubMed  Google Scholar 

  67. Glynn LM, Schetter CD, Hobel CJ, Sandman CA. Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol. 2008;27:43–51.

    Article  PubMed  Google Scholar 

  68. Field T, Diego M, Dieter J, et al. Prenatal depression effects on the fetus and the newborn. Infant Behav Dev. 2004;27:216–29.

    Article  Google Scholar 

  69. Neri F, Chimini L, Filippini E, Motta M, Faden D, Tincani A. Pregnancy in patients with rheumatic diseases: psychological implication of a chronic disease and neuropsychological evaluation of the children. Lupus. 2004;13:666–8.

    Article  PubMed  CAS  Google Scholar 

  70. Poole JL, Willer K, Mendelson C, Sanders M, Skipper B. Perceived parenting ability and systemic sclerosis. Musculoskeletal Care. 2011;9(1):32–40.

    Article  PubMed  Google Scholar 

  71. Crawford SG, Kaplan BJ, Kinsbourne M. The effects of parental immunoreactivity on pregnancy, birth, and cognitive development: maternal immune attack on the fetus? Cortex. 1992;28:483–91.

    Article  PubMed  CAS  Google Scholar 

  72. Bomba M, Galli J, Nacinovich R, Ceribelli A, Motta M, Lojacono A, Fazzi E, Tincani A. Neuropsychiatric aid in children born to patients with rheumatic diseases. Clin Exp Rheumatol. 2010;28(5):767–73.

    PubMed  CAS  Google Scholar 

  73. Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr. 2000;137(5):674–80.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angela Tincani M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nalli, C. et al. (2014). Long-Term Outcome of Children of Rheumatic Disease Patients. In: Sammaritano, L., Bermas, B. (eds) Contraception and Pregnancy in Patients with Rheumatic Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0673-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0673-4_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0672-7

  • Online ISBN: 978-1-4939-0673-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics